title: Unexpectedly high AUC levels in a child who received intravenous busulfan before stem cell transplantation.
authors.forename: T
authors.initials: T
authors.lastname: Nishikawa
authors.forename: Y
authors.initials: Y
authors.lastname: Okamoto
authors.forename: T
authors.initials: T
authors.lastname: Tanabe
authors.forename: Y
authors.initials: Y
authors.lastname: Shinkoda
authors.forename: Y
authors.initials: Y
authors.lastname: Kodama
authors.forename: M
authors.initials: M
authors.lastname: Higashi
authors.forename: H
authors.initials: H
authors.lastname: Hirano
authors.forename: K
authors.initials: K
authors.lastname: Arita
authors.forename: Y
authors.initials: Y
authors.lastname: Kawano
mesh_terms: D019540:Area Under Curve; D002066:Busulfan / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics*; D002528:Cerebellar Neoplasms / Q000628:therapy; D002648:Child; D016903:Drug Monitoring; D017809:Fatal Outcome; D005982:Glutathione Transferase / Q000235:genetics / Q000378:metabolism; D006801:Humans; D007275:Injections, Intravenous; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008297:Male; D008527:Medulloblastoma / Q000628:therapy; D019653:Myeloablative Agonists / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics*; D036102:Peripheral Blood Stem Cell Transplantation; D019172:Transplantation Conditioning / Q000009:adverse effects*; D014182:Transplantation, Autologous
chemical_list: D019653:Myeloablative Agonists; C484555:GSTA1 protein, human; D005982:Glutathione Transferase; D002066:Busulfan